EVOKE PHARMA INC

Historical 13F Holders

Symbol
EVOK
CUSIP
30049G302
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 30049G302 since 12/18/2024, largest first.

Filer % of Class Filed
Klein Roger M. 13D
10.5% 11/12/2025
Event 11/4/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Lytton, Laurence W. 13G/A 3.9% 5/15/2025
Event 3/31/2025
Morgan Stanley 13G/A
0% 12/5/2025
Event 11/30/2025
Nantahala Capital Management, LLC 13D/A
0% 12/19/2025
Event 12/17/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q3 15 591 k $2.94M
2025 Q2 11 232 k $604k
2025 Q1 11 262 k $678k
2024 Q4 9 218 k $966k
2024 Q3 13 208 k $995k